Request Demo
Last update 08 May 2025
Huadao (Shanghai) Biomedical Co., Ltd.
Last update 08 May 2025
Overview
Tags
Neoplasms
Other Diseases
Immune System Diseases
Biological products
Monoclonal antibody
Autologous CAR-T
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20232554
一项评估HD CD19 CAR-T治疗难治或复发的B细胞急性淋巴细胞白血病患者的I/II期安全性和有效性的临床试验
[Translation] A Phase I/II clinical trial evaluating the safety and efficacy of HD CD19 CAR-T in patients with refractory or relapsed B-cell acute lymphoblastic leukemia
CTR20232275
HD CD19 CAR-T治疗难治或复发的侵袭性B细胞非霍奇金淋巴瘤患者的Ib/II期确证性临床试验
[Translation] Phase Ib/II confirmatory clinical trial of HD CD19 CAR-T in patients with refractory or relapsed aggressive B-cell non-Hodgkin's lymphoma
NCT04513431
A Study Evaluating the Safety and Preliminary Efficacy of Anti-CEA CAR-T Cells for the Prevention of Postoperative Recurrence and Metastasis of Stage III Colorectal Cancer or Liver Metastasis of Colorectal Cancer
100 Clinical Results associated with Huadao (Shanghai) Biomedical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Huadao (Shanghai) Biomedical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Huadao (Shanghai) Biomedical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 10 May 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
1
IND Application
IND Approval
1
2
Phase 2 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free